Joint Venture 2019

From SensUs Wiki
Revision as of 12:49, 5 September 2020 by Techsensus (talk | contribs)
Jump to: navigation, search
Logo of Team Sanbox

Joint Venture 2019

Joint Venture is a team competing in Sensus 2019, its university is the Imperial College London. For Sensus 2019, Joint Venture investigated the possibilities for creating a biosensor which is able to measure the concentration of Adalimumab. The full TRD can be found via this link


Magnetic Microparticle Centrifugation

Molecular Recognition

Our point-of-care system makes use of a magnetic microparticle centrifugation technique coupled with the characteristic bright red colour of AuNPs1 2to give an optical readout proportional to the concentration of ADL in thepatient’s plasma.

Physical Transduction

A blood plasma sample with a high concentration of ADL will give the strongest coloured solution. Conversely, a blood plasma sample with a much lower concentration of ADL will give a near colourless supernatant. The intensity of the coloured solution is measured using a spectrophotometer.


In order to minimise our environmental impact, oursensor has been designed to rely on modified clearacrylic slides, as can be seen in Appendix II. Theseare easily produced at low cost with a minimal envi-ronmental impact caused by mass development.

Reader Instrument

Our biosensor’s screen is the main communication point for the patient, with our app ADA acting as a tool to use alongside for tracking and management. There is a large, easy to use touch screen, housed in a sensor 20 by 14 by 10 cm in size.